Molecular Partners Ag (MOLN) Shares Outstanding (Entity) (2020 - 2025)
Molecular Partners Ag (MOLN) Shares Outstanding (Entity) (2020 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 575.47 Mn |
| 10 | Molecular Partners Ag | 163.25 Mn | 163.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.37 Mn |
| Jun 30, 2025 | 40.37 Mn |
| Dec 31, 2024 | 40.36 Mn |
| Jun 30, 2024 | 36.68 Mn |
| Dec 31, 2023 | 36.35 Mn |
| Jun 30, 2023 | 36.33 Mn |
| Dec 31, 2022 | 36.04 Mn |
| Jun 30, 2022 | 32.50 Mn |
| Dec 31, 2021 | 32.29 Mn |
| Jun 30, 2021 | 29.71 Mn |
| Dec 31, 2020 | 29.15 Mn |